Please login to the form below

Not currently logged in
Email:
Password:

Crescendo Biologics appoints CFO

Theodora Harold joins the drug discovery firm

Crescendo Biologics Theodora HaroldCambridge, UK-based Crescendo Biologics has appointed Theodora Harold as its new chief financial officer.

Harold brings 20 years of pharmaceutical and corporate finance industry experience to the role, with particular expertise in growing and early stage biotech companies.

She joins from PsiOxus Therapeutics where she served as chief financial officer, and has also held a number of positions at Cytomyx Holdings, OrthoMimetics, and Mission Therapeutics.

Dr Peter Pack, chief executive officer of Crescendo Biologics, said: “Theo's appointment as Crescendo's new chief financial officer places us in an excellent position to drive ahead with our ambitious plans to create a high value pipeline of differentiated Humabody therapeutics for treating cancer indications with substantial unmet need.

“The experience that she brings to Crescendo strengthens the existing management team and is crucial in allowing us to continue building both strategic and financial value in the company.”

1st November 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics